The store will not work correctly when cookies are disabled.
N-(2-aminoethyl)-2-(biphenyl-4-yl)quinoline-5-carboxamide
ID: ALA4443539
PubChem CID: 155516641
Max Phase: Preclinical
Molecular Formula: C24H21N3O
Molecular Weight: 367.45
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: NCCNC(=O)c1cccc2nc(-c3ccc(-c4ccccc4)cc3)ccc12
Standard InChI: InChI=1S/C24H21N3O/c25-15-16-26-24(28)21-7-4-8-23-20(21)13-14-22(27-23)19-11-9-18(10-12-19)17-5-2-1-3-6-17/h1-14H,15-16,25H2,(H,26,28)
Standard InChI Key: BBOLDCISBOVEGM-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
32.7234 -13.7560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7222 -14.5756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4303 -14.9845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4285 -13.3472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1371 -13.7524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1379 -14.5714 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8464 -14.9785 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.5547 -14.5677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5499 -13.7455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8408 -13.3422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2640 -14.9735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2622 -15.7877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9707 -16.1935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6778 -15.7821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6720 -14.9607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9630 -14.5586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3859 -16.1870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3889 -17.0053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.0979 -17.4101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.8044 -16.9977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.7975 -16.1763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.0879 -15.7752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4260 -12.5300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1325 -12.1193 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.7171 -12.1235 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.0106 -12.5342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3017 -12.1277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5952 -12.5384 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
8 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
14 17 1 0
4 23 1 0
23 24 2 0
23 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 367.45 | Molecular Weight (Monoisotopic): 367.1685 | AlogP: 4.26 | #Rotatable Bonds: 5 |
Polar Surface Area: 68.01 | Molecular Species: BASE | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.16 | CX LogP: 4.09 | CX LogD: 2.34 |
Aromatic Rings: 4 | Heavy Atoms: 28 | QED Weighted: 0.55 | Np Likeness Score: -0.98 |
References
1. Hussein B, Ikhmais B, Kadirvel M, Magwaza RN, Halbert G, Bryce RA, Stratford IJ, Freeman S.. (2019) Discovery of potent 4-aminoquinoline hydrazone inhibitors of NRH:quinoneoxidoreductase-2 (NQO2)., 182 [PMID:31514018] [10.1016/j.ejmech.2019.111649] |